6 ms·
So the next step is to nationalize the facility that manufactures it, the testing of it, the distribution of it. All taxpayers will pay for it. And the ubiqui
by slowhand09 7y ago
So the next step is to nationalize the facility that manufactures it, the testing of it, the distribution of it. All taxpayers will pay for it. And the ubiquitous govt will have to compensate the drug companies for the taking of their intellectual property. Welcome to Venezuela.
- aplummer 7y agoSeriously what a ridiculous slippery slope argument, have you never been to another near identical democracy with a higher HDI than the USA? People don’t pay for insulin in any of them and yet, society functions just fine.
- toomuchtodo 7y agoInsulin is a generic. No one is required to be compensated. Pharma had their chance to be reasonable. That time has passed. Not to say that we shouldn’t appropriate intellectual property when necessary (eminent domain or not respecting a patent, as has happened in India and Canada), it’s just not necessary in this case. That doesn’t make us Venezuela, that makes us pragmatic.
- aplummer 7y agoThe inventor gave the patent away for $1 because it would have been unethical to profit from it. That’s still true.
- deleted 7y ago[deleted]
- AdrianB1 7y agoThere are different generations of insulin; the old ones are cheap, the latest ones are not. I would like to see every inventor give the patents away for free, it would be great in a way, I just don't know who will invent anything new because these days the marginal cost of improving products is astronomical. For example, building a log cabin 200 years ago was tiny, both in cost of raw materials and work. Now the cost of a house is huge, not only because different materials are used, more complex manufacturing processes are needed, but who wants to live in a log cabin? Same comparison with insulin, there is cheap insulin and expensive insulin, people want the expensive one to be cheap. Not always possible.
- jibe 7y agoGeneric Insulin is already cheap, around $100. It is the newer more effective versions that pharma companies have come up with recently that are more expensive. One can't argue that the pharma companies are bringing no value, and then demand their specific product because the generic isn't good enough. https://www.snopes.com/fact-check/insulin-walmart-vial/ https://www.snopes.com/fact-check/insulin-walmart-vial/
- toomuchtodo 7y agoOne can argue they’re attempting to capture more value than the social contract intended, and that contract will be updated through legislative action. We reserve the right as a society to update the social contract at any time.
- TallGuyShort 7y agoI never signed a social contract. Can you point me to the text? I'd like to read it, since apparently it keeps requiring me to relinquish my rights.
- toomuchtodo 7y agoGoogle for your local, state, and federal law. Your continued presence in the jurisdiction indicates your acceptance of the implicit contract defined by these laws. If it doesn’t vibe with your beliefs (which is fair!), there are other jurisdictions available for consideration, a visa and plane ticket away.
- TallGuyShort 7y agoThe laws are not the contract. I already moved where I did because I liked the laws. But the damned things keep changing because of this social contract. If the laws were the social contract, your parent comment wouldn't make sense either. Not liking the laws is one thing. Justifying new ones because of this pretend contract is another.
- pjc50 7y agoThe original development of insulin was nearly 100 years ago, so the patent has expired, and in any case was donated to the public good: https://www.treehugger.com/health/inventors-insulin-sold-their-patent-buck-why-it-so-expensive.html https://www.treehugger.com/health/inventors-insulin-sold-the...
- baroomba 7y agoYou're aware that (AFAIK) every single other OECD state uses implicit (monopsony) or explicit price controls as a key part of controlling healthcare costs and maintaining access to healthcare, right? In fact it's maybe the one factor that pretty much every non-US healthcare system shares. Even friggin' Singapore, the usual "look, the market can work!" example for healthcare, does it.